期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 20, 页码 6599-6603出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm800283k
关键词
-
资金
- Georgia Research Alliance
- Georgia Cancer Coalition
- National Institutes of Health [GM062920, GM053386]
Darunavir, a potent antiviral drug, showed an unusual second binding site on the HIV-1 protease dimer surface of the V32I drug resistant mutant and normal binding in the active site cavity. Kinetic analysis for wild type and mutant protease showed mixed-type competitive-uncompetitive inhibition for darunavir and the chemically related amprenavir, while saquinavir showed competitive inhibition. The inhibition model is consistent with the observed second binding site for darunavir and helps to explain its antiviral potency.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据